Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

KRN-23 granted orphan drug status in Europe for X-linked hypophosphatemia

Oct. 31, 2014

FDA approves Xigduo XR for type 2 diabetes

Oct. 30, 2014

Saniona acquires obesity candidate from NeuroSearch

Oct. 30, 2014

Clenbuterol earns FDA orphan drug designation as adjunctive therapy for Pompe's disease

Oct. 30, 2014

FDA grants triheptanoin orphan drug status for GLUT-1 deficiency syndrome

Oct. 30, 2014

Scientists identify miR-34a as suppressor of osteoclastogenesis and bone resorption

Oct. 29, 2014

CHMP recommends approval of Duavive

Oct. 28, 2014

Novel GPR120 modulators divulged by Bristol-Myers Squibb

Oct. 27, 2014

ProteoTech given FDA orphan drug status for AL amyloidosis candidate

Oct. 27, 2014

FDA extends PDUFA action date for Natpara BLA

Oct. 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...